Works matching IS 1470269X AND DT 2010 AND VI 10 AND IP 3

Results: 10

Prevalence of CYP2C9 polymorphisms in the south of Europe.

Published in:

2010

By:

Sánchez-Diz, P;
Estany-Gestal, A;
Aguirre, C;
Blanco, A;
Carracedo, A;
Ibáñez, L;
Passiu, M;
Provezza, L;
Ramos-Ruiz, R;
Ruiz, B;
Salado-Valdivieso, I;
Velasco, E A;
Figueiras, A

Publication type:

Correction Notice

Association of polymorphisms in the carbonic anhydrase 6 gene with salivary buffer capacity, dental plaque pH, and caries index in children aged 7–9 years.

Published in:

2010

By:

Peres, R C R;
Camargo, G;
Mofatto, L S;
Cortellazzi, K L;
Santos, M C L G;
Nobre-dos-Santos, M;
Bergamaschi, C C;
Line, S R P

Publication type:

Correction Notice

The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 3, p. 219, doi. 10.1038/tpj.2009.50

By:

Schenk, PW;
Vliet, M. van;
Mathot, RAA;
Gelder, T. van;
Vulto, AG;
Fessem, MAC van;
Rij, S Verploegh-Van;
Lindemans, J;
Bruijn, JA;
Schaik, RHN van

Publication type:

Article

Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 3, p. 232, doi. 10.1038/tpj.2009.59

By:

Proudnikov, D.;
Kroslak, T.;
Sipe, J.C.;
Randesi, M.;
Li, D.;
Hamon, S.;
Ho, A.;
Ott, J.;
Kreek, M.J.

Publication type:

Article

Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 3, p. 180, doi. 10.1038/tpj.2009.53

By:

Toffalorio, F;
Giovannetti, E;
De Pas, T;
Radice, D;
Pelosi, G;
Manzotti, M;
Minocci, D;
Spaggiari, L;
Spitaleri, G;
Noberasco, C;
Catania, C;
Boselli, S;
Danesi, R;
De Braud, F

Publication type:

Article

A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 3, p. 191, doi. 10.1038/tpj.2009.57

By:

Deeken, J.F.;
Cormier, T.;
Price, D.K.;
Sissung, T.M.;
Steinberg, S.M.;
Tran, K.;
Liewehr, D.J.;
Dahut, W.L.;
Miao, X.;
Figg, W.D.

Publication type:

Article

ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 3, p. 161, doi. 10.1038/tpj.2009.58

By:

Stone, D.J.;
Molony, C.;
Suver, C.;
Schadt, E.E.;
Potter, W.Z.

Publication type:

Article

Role of Esrrg in the fibrate-mediated regulation of lipid metabolism genes in human ApoA-I transgenic mice.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 3, p. 165, doi. 10.1038/tpj.2009.51

By:

Sanoudou, D.;
Duka, A.;
Drosatos, K.;
Hayes, K.C.;
Zannis, V.I.

Publication type:

Article

Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 3, p. 200, doi. 10.1038/tpj.2009.65

By:

Hwang, R;
Zai, C;
Tiwari, A;
Müller, DJ;
Arranz, MJ;
Morris, AG;
McKenna, PJ;
Munro, J;
Potkin, SG;
Lieberman, JA;
Kennedy, JL;
Meltzer, HY

Publication type:

Article

The modulating effect of the androgen receptor on craving in alcohol withdrawal of men is partially mediated by leptin.

Published in:

Pharmacogenomics Journal, 2010, v. 10, n. 3, p. 226, doi. 10.1038/tpj.2009.56

By:

Lenz, B;
Frieling, H;
Jacob, C;
Heberlein, A;
Kornhuber, J;
Bleich, S;
Hillemacher, T

Publication type:

Article